Nutritional status in patients with COVID-19 and cancer: the experience of the National Cancer Institute in Mexico

被引:3
|
作者
Perez Camargo, Dana Aline [1 ,7 ]
Vargas Gutierrez, Gaspar [1 ]
Rivera Franco, Monica M. [6 ]
Labana Ramirez, Anabel [1 ]
Castro Herrera, Monserrat [1 ]
Urbalejo Ceniceros, Victor Itai [2 ]
Copca Mendoza, Erika Thalia [1 ]
Loyola Serrano, Osiris [1 ]
Baltazar Luna, Erendira [1 ]
Meneses Garcia, Abelardo [4 ]
Herrera Gomez, Angel [5 ]
Gonzalez Enciso, Aaron [3 ]
Sevilla Gonzalez, Maria de la Luz [7 ]
机构
[1] Inst Nacl Cancerol, Dept Nutr, Ave San Fernando 22,Belisario Dominguez Secc XVI, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Dept Hematol, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Dept Surg, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Dept Gen Directorship, Mexico City, DF, Mexico
[5] Inst Nacl Cancerol, Dept Med Directorship, Mexico City, DF, Mexico
[6] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol & Oncol, Mexico City, DF, Mexico
[7] Inst Politecn Nacl, Fac Med, Postgrad & Res Dept, Mexico City, DF, Mexico
关键词
Body mass index; Cancer; COVID-19; Mortality; Nutrition;
D O I
10.20960/nh.03683
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: nutritional status might vary according to different underlying illnesses such as cancer or infectious diseases, including COVID-19. In this context, data from developing countries remain scarce. Objectives: the objective of this study was to assess the nutritional status and outcomes of Mexican cancer patients diagnosed with COVID-19 at a tertiary care center. Methods: this was a retrospective study including 121 consecutive cancer patients diagnosed with COVID-19 at the National Cancer Institute, Mexico City, during four months. Results: the most frequent oncological diagnoses were gynecological (19 %) and hematological (17 %). Most patients were overweight (35 %). In the univariate analysis, >= 65 years, intubation, hypoalbuminemia, high creatinine, lymphopenia, nutrition-impact symptoms, and ECOG 2-4 were statistically associated with lower survival. The median survival of the cohort was 41 days. Conclusions: to our best knowledge, this is the first study of its kind performed in Mexico, and as other studies from other regions, our results might aid in identifying cancer patients most at risk for severe COVID-19, and could be potentially useful to enhance public health messaging on self-isolation and social distancing among Mexican cancer patients.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [41] COVID-19 in cancer patients
    Seneviratne, Suranjith L.
    Wijerathne, Widuranga
    Yasawardene, Pamodh
    Somawardana, Buddhika
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (09) : 767 - 797
  • [42] COVID-19 in patients with cancer
    Smotherman, Carmen
    Norez, Daniel
    Austin-Datta, Rebecca
    Yaghjyan, Lusine
    LANCET ONCOLOGY, 2020, 21 (12): : E539 - E539
  • [43] COVID-19 and patients with cancer
    Chahal, Aksh
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2021, 28 (05):
  • [44] Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis.
    Loggers, Elizabeth Trice
    Wulff-Burchfield, Elizabeth Marie
    Subbiah, Ishwaria Mohan
    Khaki, Ali Raza
    Egan, Pamela
    Farmakiotis, Dimitrios
    Phull, Hardeep
    Nakasone, Elizabeth
    Labaki, Chris
    Yu, Peter Paul
    Joshi, Monika
    Griffiths, Elizabeth A.
    Wise-Draper, Trisha Michel
    Jani, Chinmay
    Thakkar, Astha
    Puc, Matthew
    Hwang, Clara
    Mavromatis, Blanche H.
    Shah, Dimpy P.
    Warner, Jeremy Lyle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
    Cherif, Ines
    Khiari, H.
    M'ghirbi, F.
    Mallekh, R.
    Mezlini, A.
    Hsairi, M.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 359 - 359
  • [46] Skin sparing mastectomy. Experience of the National Cancer Institute of Mexico
    Robles-Vidal, CD
    Arteaga, C
    Villarreal-Colin, P
    Drucker, M
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S72 - S72
  • [47] Acute stroke during the COVID-19 pandemic. Experience from the National Institute of Neurology and Neurosurgery, Mexico
    Medina-Rioja, Raul
    Saldivar-Davila, Sergio
    Manuel Calleja-Castillo, Juan
    NEUROLOGY, 2021, 96 (15)
  • [48] NATIONAL CANCER INSTITUTE EXPERIENCE WITH TESTICULAR CANCER
    JAVADPOUR, N
    JOURNAL OF UROLOGY, 1978, 120 (06): : 651 - 659
  • [49] Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
    Pietrantonio, Filippo
    Morano, Federica
    Niger, Monica
    Corallo, Salvatore
    Antista, Maria
    Raimondi, Alessandra
    Prisciandaro, Michele
    Pagani, Filippo
    Prinzi, Natalie
    Nichetti, Federico
    Randon, Giovanni
    Torchio, Martina
    Corti, Francesca
    Ambrosini, Margherita
    Palermo, Federica
    Palazzo, Michele
    Biamonte, Lavinia
    Platania, Marco
    Sposito, Carlo
    Cosimelli, Maurizio
    Mazzaferro, Vincenzo
    Pusceddu, Sara
    Cremolini, Chiara
    de Braud, Filippo
    Di Bartolomeo, Maria
    CLINICAL COLORECTAL CANCER, 2020, 19 (03) : 156 - 164
  • [50] Clinical and Nutritional Aspects and Outcomes of Covid-19 in Cancer and Non-Cancer Pediatric Patients
    Reis, Greice Milena Sant'Ana
    Clemente, Heleni Aires
    da Silva, Jose Adailton
    Barros Neto, Joao Araujo
    de Oliveira, Alane Cabral Menezes
    Mello, Carolina Santos
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025, 77 (02): : 179 - 187